bilaterals.org logo
bilaterals.org logo

intellectual property


Farm tariffs, IPRs seen as main obstacles to US-Andean FTA
Tariffs on agricultural products and definitions of intellectual property rights, particularly for pharmaceuticals, are shaping up as the most contentious issues in the free trade negotiations between the United States and three Andean nations, Colombia, Ecuador, and Peru.
Intellectual Property: We must not make any concession on medicines
The Colombian Germán Velásquez says that it was unfair for the US to veto the Argentine advisor Carlos Correa. He claims that poor countries must continue to have access to cheap medicines even if there are trade treaties. His request is that the Doha agreement is respected.
POLICY REVERSAL: Green light for GMOs
Prime Minister Thaksin Shinawatra yesterday bestowed the government’s tacit blessing on the planting and trading of genetically modified (GM) crops by revoking an earlier ban on their commercial use, in defiance of wide opposition from farmers, environmentalists and consumer networks.
USTR statement on Australia’s amendments
We understand that the FTA implementing legislation and amendments pose important issues in Australia, just as they did in the United States.
Senate passes FTA deal amid US warning
The Coalition and Labor combined to pass the legislation after two weeks of debate in Senate, but the deal could still come unstuck if the US decides Australia’s supporting legislation including Labor’s amendments are not consistent with the agreement.
Selling off a slice of our country
The funny thing about the free trade agreement with the United States is that Australians and Americans see it as being about completely different things. Australia’s businesspeople see it as about eliminating the barriers to exports and imports between the two countries, which they regard as a good thing.
Australian Linux bodies blast US free-trade deal
Australia’s national open source industry body, OSIA (Open Source Industry Australia), and Linux Australia have spoken out about their concerns over the proposed Australian-US Free Trade Agreement (AUSFTA), warning that the legal framework of the intellectual property clauses will put the entire Australian software development industry at risk.
FTA set to increase medicine prices
Kerryn Williams spoke to David Henry, clinical pharmacology professor at Newcastle University and former Pharmaceutical Benefits Advisory Committee member, about how the proposed US-Australia Free Trade Agreement will undermine the Pharmaceutical Benefits Scheme, and increase the price of medicine.
Letter urging IP be excluded from US-SACU trade negotiations
Re: Excluding Intellectual Property from negotiations over a U.S.- Southern African Customs Union (SACU) Free Trade Agreement
’Free’ trade beyond the WTO
Welcome to the brave new world of “Free” Trade. This is a world that extends beyond the World Trade Organisation. This may be difficult to comprehend, but the fact of the matter is that global capital, led by the US government, seeks more and more to tread where even the WTO did not.
Thailand: Govt accused of lying about drugs in FTA Trade pact
The government lied when it said it would exclude medicines from the list of products included under the prospective freetrade agreement between Thailand and the United States, a seminar was told yesterday.
Tridge fears FTA patent war
One of Australia’s most recognised Linux developers, Dr Andrew Tridgell, has attacked the proposed Australia-US Free Trade Agreement (FTA), claiming it could pit local open source developers against Microsoft in a "patent war".
Taiwan: US trade envoy to examine IPR progress
Charles Freeman, assistant US trade representative for China affairs, is scheduled to meet officials at the Ministry of Economic Affairs today, marking the first trade talks between the two countries since October 2002, a government official said yesterday.
The disease of the day: Acute treatyitis
The efforts to establish global and regional ‘free trade’ agreements have met with considerable resistance. People around the world suffering the effects of so-called free trade have steadily built a movement to reject the dominant economic model.
In New Trade Pacts, U.S. Seeks To Limit Reach of Generic Drugs
As public-health groups urge wider use of generic drugs to lower the cost of treating AIDS and other diseases in developing countries, U.S. trade negotiators — prodded by the drug industry — are taking the opposite stance in new trade pacts, seeking to strengthen protections for costlier brand-name drugs.
Cheap HIV Drugs: Scepticism over Thaksin’s pledge
Critics voiced doubt yesterday over Prime Minister Thaksin Shinawatra’s promise to provide equitable access to life-saving drugs for all people with HIV/Aids in Thailand, saying it was a pipe dream while disputes over patented drugs remain unresolved.
Big FTA stoush brewing on copyright
A full-scale political stoush is brewing over intellectual property provisions in the Australia-US free trade agreement following the passage of enabling legislation last week.
Reports highlight costs of free trade deal
Politicians from Australia’s opposition party could try to derail the Australian-US Free Trade Agreement (AUSFTA) after a Senate select committee claimed the deal could push up drugs prices and give copyright owners in Australia even more protection than they enjoy in the US.
FTA undermines principle of affordable drugs for all
The Australian Senate should delay implementing legislation for the Free Trade Agreement with the US. Countries such as Brazil and Thailand, with large generic pharmaceutical industries, are looking to Australia for leadership in countering this US bilateral push for global uniformly of high pharmaceutical prices through aggressive intellectual property (IP) protection.